Gestalt Diagnostics
Gestalt Diagnostics is a Spokane-based digital pathology company that provides a cloud-based, vendor-neutral platform (PathFlow) unifying whole slide imaging, case management, and AI integration for academic medical centers, reference labs, and pathology groups. It sells via enterprise subscriptions, professional services, and channel partners.
- Company typePrivate
- Founded2017
- HeadquartersSpokane, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Gestalt Diagnostics does
Gestalt Diagnostics, founded in 2017 and headquartered in Spokane, Washington, is an AI-powered digital pathology platform company serving academic medical centers, integrated health networks, reference laboratories, and private pathology groups. The company operates a cloud-based, vendor-neutral platform architecture anchored by PathFlow, which unifies whole slide image viewing, case management, and patient data in a single environment with configurable Anatomic Pathology, Education, and Research modules. Supporting products include PathCloud for web-based image sharing and collaboration, Health Data Cloud for healthcare data interoperability, Electronic Lab Reporting for public health submissions, and LIS migration and IT staff augmentation services. Gestalt's AI capabilities are delivered through an open AI Portfolio that integrates third-party and custom AI applications into the diagnostic workflow, with validated interoperability across 8 of 9 major WSI scanner brands and multiple AI Evidence Creators demonstrated at the 2025 DICOM WG-26 Connectathon.
The company makes money primarily through enterprise subscription licensing of the PathFlow platform, supplemented by professional services revenue from implementation, LIS migration, custom AI development, and ongoing IT support. Pricing is not publicly disclosed and follows a quote-based consultative sales motion targeting enterprise buyers, with a 'Request a Demo' primary call-to-action and white-glove onboarding. Gestalt sells through a direct enterprise field sales force complemented by channel partnerships including DLS for international markets and Voicebrook for joint go-to-market with speech-enabled reporting. The customer base spans 25+ named organizations across enterprise and mid-market tiers, including Johns Hopkins Medicine, NYU Langone Health, UCLA Health, Stanford Medicine, ARUP Laboratories, BioReference Laboratories, Moffitt Cancer Center, Baylor Scott & White Health, Northwell Health, and Baptist Health South Florida.
In April 2025, Gestalt closed a $7.5 million Series A round led by Cowles Ventures and TVF Funds, with capital directed toward AI capability enhancement, FDA clearance pursuits, and customer base expansion. The company maintains HIPAA, SOC 2 Type II, and CE-IVD certifications, holds registered trademarks for PathFlow and PathCloud, and has strategic partnerships with Optum (UnitedHealth Group), Voicebrook, Primaa, AIRA Matrix, OmniPathology, and Leica Biosystems. Recent product milestones include PathFlow Version 6 (October 2025), the Voicebrook speech-enabled integration (September 2025), and the first African client onboarding (DataPathology, March 2025).
Gestalt Diagnostics firmographics
Firmographics- Name
- Gestalt Diagnostics
- Legal name
- Gestalt Diagnostics
- Website
- https://gestaltdiagnostics.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Gestalt Diagnostics is a Spokane-based digital pathology company that provides a cloud-based, vendor-neutral platform (PathFlow) unifying whole slide imaging, case management, and AI integration for academic medical centers, reference labs, and pathology groups. It sells via enterprise subscriptions, professional services, and channel partners.
- Ownership category
- akta.pro rank
Gestalt Diagnostics industry classification
Industry- Product category
- Digital Pathology Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Anatomic Pathology LIS & Digital Pathology Workflow (HLACAMAB)
- akta.pro secondary industries
- Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Medical Imaging AI (HDAAAEAH), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)
Keywords
Where Gestalt Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Spokane
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Gestalt Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Platform Subscription: Subscription-based access to PathFlow and PathCloud digital pathology platforms. Likely tiered based on modules, users, or volume.
- Professional Services: Implementation, onboarding, training, and ongoing support services. Includes staff augmentation for healthcare IT teams.
- AI Solutions: AI Portfolio and custom AI solutions integrated into the platform, likely bundled or add-on to core subscription.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Gestalt Diagnostics product offering
Product offeringCore offering
Gestalt Diagnostics sells a cloud-based enterprise digital pathology platform called PathFlow that unifies whole slide image viewing, case management, and patient data for anatomic pathology, education, and research workflows. The offering is complemented by PathCloud for web-based image sharing, Health Data Cloud for interoperability with EHR/LIS systems, Electronic Lab Reporting, AI Portfolio (open AI infrastructure), AI Custom Solutions, and IT services such as LIS migration and outsourced support. Customers are primarily healthcare systems, academic medical centers, and private pathology laboratories.
Product overview
Gestalt Diagnostics offers a unified digital pathology platform architecture centered on PathFlow®, a cloud-based enterprise digital pathology system with modular components. The platform consists of three integrated modules—Anatomic Pathology (clinical diagnostic), Education, and Research—providing flexibility for facilities to mix and match based on their operational needs. Supporting the core platform are complementary products including PathCloud® for web-based image sharing and collaboration, Health Data Cloud for healthcare interoperability, and Electronic Lab Reporting (ELR) for public health compliance. AI capabilities are delivered through the AI Portfolio (open infrastructure for third-party AI integration) and AI Custom Solutions (custom development services). IT services including LIS Migration, Outsource LIS Support, and Healthcare IT Staff Augmentation support implementation and ongoing operations. The platform is vendor-neutral, integrating with Epic and Cerner EHR systems, WSI scanners from multiple manufacturers, and AI annotation tools from vendors like Visiopharm, Hologic, TechCyte, and identify.bio.
Differentiator
Problem solved
Functional benefit
Brands
- PathFlow®: Digital pathology platform that unifies image, case, and patient management in a single, automated environment for pathologists.
- PathCloud®
- Health Data Cloud
Products and services
- PathFlow PathFlow is Gestalt's primary cloud-based digital pathology platform that unifies image, case, and patient management in a single automated environment for pathology laboratories, with configurable workflows supporting Anatomic Pathology, Education, and Research modules. It is designed for health systems, academic medical centers, reference laboratories, and hospital labs.
- PathCloud PathCloud is a secure, web-based interface for digital image sharing and collaboration that helps organizations adopt digital pathology without heavy infrastructure investment or workflow disruption. It is intended for pathologists and labs needing lightweight, browser-based access to whole slide images.
- Health Data Cloud Health Data Cloud is a healthcare-compliant, web-based interface engine that connects healthcare applications and reporting agencies, enabling reliable, standards-based data exchange across healthcare IT systems. It targets healthcare organizations requiring interoperability between LIS, EHR, and reporting systems.
- Electronic Lab Reporting (ELR) Electronic Lab Reporting (ELR) is an automated laboratory reporting service for reportable diseases and cancer reporting to public health and regulatory agencies, ensuring timely, validated data submission. It is used by hospital and reference laboratories with public health compliance obligations.
- LIS Migration LIS Migration is an end-to-end laboratory information system migration service that manages patient, case, and workflow data transitions with minimal downtime while preserving existing integrations. It is targeted at laboratories transitioning between LIS platforms or consolidating multi-LIS environments.
- Outsourced LIS Support Services Outsourced LIS Support Services provide expert ongoing LIS support that maintains system stability, resolves issues quickly, and extends existing LIS investments without adding internal IT strain. It targets hospital and reference laboratories seeking external operational support for their LIS.
- Healthcare IT Staff Augmentation Healthcare IT Staff Augmentation provides flexible staffing of experienced healthcare IT professionals to augment internal teams for integrations, implementations, and modernization initiatives. It targets healthcare organizations needing surge IT capacity for digital pathology and LIS projects.
- AI Portfolio AI Portfolio is an open AI infrastructure that integrates clinically validated AI applications directly into the PathFlow workflow, supporting third-party AI tools and enabling pathologist choice, control, and clinical workflow alignment. It is intended for pathology groups that want access to multiple AI algorithms within a single viewer environment.
- AI Custom Solutions AI Custom Solutions is a custom AI development service that enables organizations to build tailored AI solutions integrated into PathFlow for specific diagnostic and operational needs. It targets pathology groups, health systems, and research institutions with specialized AI requirements that off-the-shelf tools cannot meet.
Quantifiable outcome
- Integrated automation has enabled some labs to reduce manual steps by approximately 75%
- +2 more outcomes
Companies that use Gestalt Diagnostics
Customer profileNamed customers25 records
Segments6 records
Ideal customer profiles5 records
Gestalt Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration12 records
AI capability8 records
Feature8 records
Gestalt Diagnostics partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and strategic.
- OmniPathologycoreOctober 2025 partnership where OmniPathology selected Gestalt's PathFlow as their digital platform and strategic partner. Focus on precision, scalability, interoperability, and global diagnostic equity with initiatives to extend digital diagnostics to underserved regions.
- VoicebrookcoreSeptember 2025 announcement of seamless integration between Voicebrook's VoiceOver PRO reporting platform and Gestalt's PathFlow. Industry's first fully speech-enabled digital pathology solution enabling pathologists to control image navigation and report creation by voice.
- PrimaacoreMarch 2025 partnership to advance AI-powered skin cancer detection through integrated digital pathology solutions. Collaboration focuses on dermatopathology tools combining Primaa's AI capabilities with Gestalt's PathFlow platform.
- AIRA MatrixcoreMarch 2025 partnership to elevate diagnostics with AI-driven QC platform. Integrates AIRA Matrix's quality control AI capabilities into Gestalt's digital pathology workflow.
- DLS (DataLink Solutions)strategicMarch 2025 reseller agreement enabling global expansion. DLS serves as reseller for Gestalt's digital pathology solutions in international markets.
- Optum (UnitedHealth Group)coreNovember 2024 partnership adding Gestalt to Optum's Digital Diagnostic Suite. Strategic integration of Gestalt's digital pathology capabilities into Optum's healthcare ecosystem.
- DataPathologystrategicFirst client in Africa - DataPathology represents Gestalt's international expansion into African markets.
- Leica BiosystemsstrategicHardware partnership referenced in customer context. BioReference Laboratories paired Leica's hardware system with Gestalt's pathology workflow platform for innovative digital workflow.
Scale indicators5 records
Recent moves6 records
Expansion highlights7 records
Gestalt Diagnostics competitors and assessment
Company assessmentDirect peers
- Proscia: Proscia is a digital pathology platform company offering Concentriq, an enterprise pathology workflow platform with AI integration and multi-WSI-scanner support, directly competing with Gestalt's PathFlow for academic medical centers, reference labs, and IDN contracts.
- PathAI: PathAI provides AI-powered pathology solutions and a digital pathology workflow platform (AISight), serving biopharma, academic centers, and clinical labs with integrated AI diagnostics and image management - closely aligned with Gestalt's platform-plus-AI offering.
- Ibex Medical Analytics: Ibex develops AI-powered cancer diagnostics deployed within pathology workflows, with both standalone AI algorithms and an integrated pathology platform - a direct competitor to Gestalt's AI Portfolio and PathFlow strategy.
- Indica Labs: Indica Labs provides Halo and HALO AP digital pathology software for image analysis, AI integration, and pathology workflow - competing with Gestalt in anatomic pathology image management and AI deployment.
- Visiopharm: Visiopharm offers AI-driven pathology image analysis and workflow software (Phenoptics, Oncotopix), and is integrated with Gestalt via the DICOM WG-26 Connectathon as an AI Evidence Creator - a peer in AI pathology and a partner/competitor on the algorithm side.
Emerging players
- Owkin: Owkin applies AI to pathology and other clinical data, with both biopharma services and emerging clinical pathology offerings - an emerging peer in AI-enabled diagnostics with partial overlap to Gestalt's AI Portfolio direction.
- AIRA Matrix: AIRA Matrix provides AI solutions for pathology and life sciences, including the AI-driven quality control platform that Gestalt integrated in March 2025 - both an emerging AI pathology peer and a tactical technology partner.
Broad incumbents
- Philips Digital Pathology: Philips offers IntelliSite Pathology Solution with enterprise WSI scanners and image management software - a broad incumbent whose bundled hardware/software offering competes with Gestalt's vendor-neutral platform, particularly in large IDN deployments.
- Roche (Ventana): Roche's Ventana Digital Pathology platform combines slide scanners, image management software, and AI algorithms (including partnerships with PathAI) - a broad incumbent and one of the most formidable competitors to standalone digital pathology vendors.
- Leica Biosystems: Leica Biosystems offers Aperio digital pathology scanners and enterprise image management, with hardware integration partnerships across the industry - a broad incumbent whose hardware footprint shapes the market in which Gestalt's vendor-neutral software competes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Gestalt Diagnostics social profiles
Digital presenceGestalt Diagnostics compliance and trust
Trust signalCompliance4 records
Gestalt Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gestalt Diagnostics leadership team
Management profileNumber of profiles
Profiles5 records
Gestalt Diagnostics funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gestalt Diagnostics M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gestalt Diagnostics
What does Gestalt Diagnostics do?
Gestalt Diagnostics sells a cloud-based enterprise digital pathology platform called PathFlow that unifies whole slide image viewing, case management, and patient data for anatomic pathology, education, and research workflows. The offering is complemented by PathCloud for web-based image sharing, Health Data Cloud for interoperability with EHR/LIS systems, Electronic Lab Reporting, AI Portfolio (open AI infrastructure), AI Custom Solutions, and IT services such as LIS migration and outsourced support. Customers are primarily healthcare systems, academic medical centers, and private pathology laboratories.
Is Gestalt Diagnostics a public or private company?
Gestalt Diagnostics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Gestalt Diagnostics founded?
Gestalt Diagnostics was founded in 2017. It employs 11 to 50 people.
Where is Gestalt Diagnostics based?
Gestalt Diagnostics is headquartered in Spokane, United States, in the North America region.
How does Gestalt Diagnostics make money?
Three revenue lines are on record. Software Platform Subscription is the primary driver. The others are professional Services and AI Solutions.
Who are Gestalt Diagnostics's main competitors?
Direct peers on record are Proscia, PathAI, Ibex Medical Analytics, Indica Labs and Visiopharm. Emerging players are Owkin and AIRA Matrix. Broad incumbents are Philips Digital Pathology, Roche (Ventana) and Leica Biosystems.
Does Gestalt Diagnostics have an API?
No public API is recorded for Gestalt Diagnostics.
What industry is Gestalt Diagnostics in?
Gestalt Diagnostics's product category is Digital Pathology Software. Its primary akta.pro industry code is HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow, with a secondary code of HLACABAM, Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity). Its NAICS code is 5132 and its SIC code is 7372.